In the perpetual pursuit of a more efficient clinical research process, biopharmaceutical sponsors and contract research organizations (CROs) have traditionally focused their resources on the more costly and time-consuming aspects of study start-up such as protocol development, regulatory and ethical review, and data management and analysis. Investigator site contracting and management of site payments are often overlooked as opportunities to accelerate study start-up and to reduce the expense and complications of managing study site contractual relationships.

However, by targeting this smaller, yet still significant, aspect of study start-up, sponsors and CROs can expedite the process of contract negotiation, reducing both the cycle time and burden on the legal infrastructure.  

Download this whitepaper to learn more.